{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:59:55Z","timestamp":1772081995843,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,6,9]],"date-time":"2012-06-09T00:00:00Z","timestamp":1339200000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00253-012-4171-4","type":"journal-article","created":{"date-parts":[[2012,6,20]],"date-time":"2012-06-20T14:53:43Z","timestamp":1340204023000},"page":"357-366","source":"Crossref","is-referenced-by-count":17,"title":["Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein"],"prefix":"10.1007","volume":"96","author":[{"given":"Lina","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingshuang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dexin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mifang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,9]]},"reference":[{"issue":"14","key":"4171_CR1","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","volume":"79","author":"AB Bakker","year":"2005","unstructured":"Bakker AB, Marissen WE, Kramer RA, Rice AB, Weldon WC, Niezgoda M, Hanlon CA, Thijsse S, Backus HH, de Kruif J, Dietzschold B, Rupprecht CE, Goudsmit J (2005) Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants. J Virol 79(14):9062\u20139068","journal-title":"J Virol"},{"issue":"47","key":"4171_CR2","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","volume":"26","author":"AB Bakker","year":"2008","unstructured":"Bakker AB, Python C, Kissling CJ, Pandya P, Marissen WE, Brink MF, Lagerwerf F, Worst S, van Corven E, Kostense S, Hartmann K, Weverling GJ, Uytdehaag F, Herzog C, Briggs DJ, Rupprecht CE, Grimaldi R, Goudsmit J (2008) First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Vaccine 26(47):5922\u20135927","journal-title":"Vaccine"},{"issue":"7","key":"4171_CR3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0167-7799(96)10029-9","volume":"14","author":"CF Barbas 3rd","year":"1996","unstructured":"Barbas CF 3rd, Burton DR (1996) Selection and evolution of high-affinity human anti-viral antibodies. Trends Biotechol 14(7):230\u2013234","journal-title":"Trends Biotechol"},{"issue":"7","key":"4171_CR4","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1073\/pnas.88.18.7978","volume":"88","author":"CF Barbas 3rd","year":"1991","unstructured":"Barbas CF 3rd, Kang A, Lerner RA, Benkovic SJ (1991) Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 88(7):7978\u20137982","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"4171_CR5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-1759(87)90187-6","volume":"100","author":"JD Beatty","year":"1987","unstructured":"Beatty JD, Beatty BG, Vlahos WG (1987) Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 100(1\u20132):173\u2013179","journal-title":"J Immunol Methods"},{"issue":"8","key":"4171_CR6","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/JVI.65.8.4198-4203.1991","volume":"65","author":"A Benmansour","year":"1991","unstructured":"Benmansour A, Leblois H, Coulon P, Tuffereau C, Gaudin Y, Flamand A, Lafay F (1991) Antigenicity of rabies virus glycoprotein. J Virol 65(8):4198\u20134203","journal-title":"J Virol"},{"issue":"1\u20132","key":"4171_CR7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-1759(99)00223-9","volume":"235","author":"JM Champion","year":"2000","unstructured":"Champion JM, Kean RB, Rupprecht CE, Notkins AL, Koprowski H, Dietzschold B, Hooper DC (2000) The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure. J Immunol Methods 235(1\u20132):81\u201390","journal-title":"J Immunol Methods"},{"issue":"6","key":"4171_CR8","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/JVI.64.6.3087-3090.1990","volume":"64","author":"B Dietzschold","year":"1990","unstructured":"Dietzschold B, Gore M, Casali P, Ueki Y, Rupprecht CE, Notkins AL, Koprowski H (1990) Biological characterization of human monoclonal antibodies to rabies virus. J Virol 64(6):3087\u20133090","journal-title":"J Virol"},{"issue":"5","key":"4171_CR9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/hyb.1991.10.547","volume":"10","author":"K Enssle","year":"1991","unstructured":"Enssle K, Kurrle R, Kohler R, Muller H, Kanzy EJ, Hilfenhaus J, Seiler FR (1991) A rabies-specific human monoclonal antibody that protects mice against lethal rabies. Hybridoma 10(5):547\u2013556","journal-title":"Hybridoma"},{"issue":"6","key":"4171_CR10","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/500470","volume":"193","author":"J Goudsmit","year":"2006","unstructured":"Goudsmit J, Marissen WE, Weldon WC, Niezgoda M, Hanlon CA, Rice AB, Kruif J, Dietzschold B, Bakker AB, Rupprecht CE (2006) Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. J Infect Dis 193(6):796\u2013801","journal-title":"J Infect Dis"},{"issue":"28\u201329","key":"4171_CR11","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/S0264-410X(01)00135-9","volume":"19","author":"CA Hanlon","year":"2001","unstructured":"Hanlon CA, DeMattos CA, DeMattos CC, Niezgoda M, Hooper DC, Koprowski H, Notkins A, Rupprecht CE (2001a) Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis. Vaccine 19(28\u201329):3834\u20133842","journal-title":"Vaccine"},{"issue":"17\u201319","key":"4171_CR12","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0264-410X(00)00516-8","volume":"19","author":"CA Hanlon","year":"2001","unstructured":"Hanlon CA, Niezgoda M, Morrill PA, Rupprecht CE (2001b) The incurable wound revisited: progress in human rabies prevention? Vaccine 19(17\u201319):2273\u20132279","journal-title":"Vaccine"},{"issue":"2","key":"4171_CR13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jviromet.2009.06.018","volume":"161","author":"M Houimel","year":"2009","unstructured":"Houimel M, Dellagi K (2009) Isolation and characterization of human neutralizing antibodies to rabies virus derived from a recombinant immune antibody library. J Virol Methods 161(2):205\u2013215","journal-title":"J Virol Methods"},{"key":"4171_CR14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.med.58.061705.145053","volume":"58","author":"ABHB John de Kruif","year":"2007","unstructured":"John de Kruif ABHB, Marissen WE, Kramer RA, Throsby M, Rupprecht CE, Goudsmit J (2007) A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis. Annu Rev Med 58:359\u2013368","journal-title":"Annu Rev Med"},{"issue":"16","key":"4171_CR15","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.0801367105","volume":"105","author":"AK Kashyap","year":"2008","unstructured":"Kashyap AK, Steel J, Oner AF, Dillon MA, Swale RE, Wall KM, Perry KJ, Faynboym A, Ilhan M, Horowitz M, Horowitz L, Palese P, Bhatt RR, Lerner RA (2008) Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci U S A 105(16):5986\u20135991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"4171_CR16","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/eji.200526134","volume":"35","author":"RA Kramer","year":"2005","unstructured":"Kramer RA, Marissen WE, Goudsmit J, Visser TJ, Clijsters-Van der Horst M, Bakker AQ, de Jong M, Jongeneelen M, Thijsse S, Backus HH, Rice AB, Weldon WC, Rupprecht CE, Dietzschold B, Bakker AB, de Kruif J (2005) The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries. Eur J Immunol 35(7):2131\u20132145","journal-title":"Eur J Immunol"},{"issue":"Pt 4","key":"4171_CR17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1099\/0022-1317-64-4-843","volume":"64","author":"M Lafon","year":"1983","unstructured":"Lafon M, Wiktor TJ, Macfarlan RI (1983) Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. J Gen Virol 64(Pt 4):843\u2013851","journal-title":"J Gen Virol"},{"key":"4171_CR18","first-page":"219","volume":"57","author":"M Lafon","year":"1984","unstructured":"Lafon M, Ideler J, Wunner WH (1984) Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies. Dev Biol Stand 57:219\u2013225","journal-title":"Dev Biol Stand"},{"issue":"1\u20132","key":"4171_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-1759(00)00322-7","volume":"247","author":"M Liang","year":"2001","unstructured":"Liang M, Dubel S, Li D, Queitsch I, Li W, Bautz EK (2001) Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments. J Immunol Methods 247(1\u20132):119\u2013130","journal-title":"J Immunol Methods"},{"issue":"8","key":"4171_CR20","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","volume":"79","author":"WE Marissen","year":"2005","unstructured":"Marissen WE, Kramer RA, Rice A, Weldon WC, Niezgoda M, Faber M, Slootstra JW, Meloen RH, Clijsters-van der Horst M, Visser TJ, Jongeneelen M, Thijsse S, Throsby M, de Kruif J, Rupprecht CE, Dietzschold B, Goudsmit J, Bakker AB (2005) Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. J Virol 79(8):4672\u20134678","journal-title":"J Virol"},{"issue":"11","key":"4171_CR21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1348-0421.2010.00262.x","volume":"54","author":"T Matsumoto","year":"2010","unstructured":"Matsumoto T, Yamada K, Noguchi K, Nakajima K, Takada K, Khawplod P, Nishizono A (2010) Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus. Microbiol Immunol 54(11):673\u2013683","journal-title":"Microbiol Immunol"},{"issue":"7","key":"4171_CR22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00705-009-0408-7","volume":"154","author":"T Muller","year":"2009","unstructured":"Muller T, Batza HJ, Beckert A, Bunzenthal C, Cox JH, Freuling CM, Fooks AR, Frost J, Geue L, Hoeflechner A, Marston D, Neubert A, Neubert L, Revilla-Fernandez S, Vanek E, Vos A, Wodak E, Zimmer K, Mettenleiter TC (2009) Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria. Arch Virol 154(7):1081\u20131091","journal-title":"Arch Virol"},{"issue":"1","key":"4171_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.62.1.1-7.1988","volume":"62","author":"C Prehaud","year":"1988","unstructured":"Prehaud C, Coulon P, LaFay F, Thiers C, Flamand A (1988) Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J Virol 62(1):1\u20137","journal-title":"J Virol"},{"issue":"2","key":"4171_CR24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0042-6822(89)90551-5","volume":"173","author":"C Prehaud","year":"1989","unstructured":"Prehaud C, Takehara K, Flamand A, Bishop DH (1989) Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors. Virology 173(2):390\u2013399","journal-title":"Virology"},{"issue":"1","key":"4171_CR25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","volume":"188","author":"M Prosniak","year":"2003","unstructured":"Prosniak M, Faber M, Hanlon CA, Rupprecht CE, Hooper DC, Dietzschold B (2003) Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies. J Infect Dis 188(1):53\u201356","journal-title":"J Infect Dis"},{"issue":"1","key":"4171_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cimid.2007.11.004","volume":"32","author":"RM Redwan el","year":"2009","unstructured":"Redwan el RM, Fahmy A, El Hanafy A, Abd El-Baky N, Sallam SM (2009) Ovine anti-rabies antibody production and evaluation. Comp Immunol Microbiol Infect Dis 32(1):9\u201319","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"25","key":"4171_CR27","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","volume":"351","author":"CE Rupprecht","year":"2004","unstructured":"Rupprecht CE, Gibbons RV (2004) Clinical practice. Prophylaxis against rabies. N Engl J Med 351(25):2626\u20132635","journal-title":"N Engl J Med"},{"issue":"6","key":"4171_CR28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(02)00287-6","volume":"2","author":"CE Rupprecht","year":"2002","unstructured":"Rupprecht CE, Hanlon CA, Hemachudha T (2002) Rabies re-examined. Lancet Infect Dis 2(6):327\u2013343","journal-title":"Lancet Infect Dis"},{"key":"4171_CR29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jviromet.2009.05.018","volume":"161","author":"S Shiota","year":"2009","unstructured":"Shiota S, Mannen K, Matsumoto T, Yamada K, Yasui T, Takayama K, Kobayashi Y, Khawplod P, Gotoh K, Ahmed K, Iha H, Nishizono A (2009) Development and evaluation of a rapid neutralizing antibody test for rabies. J Virol Methods 161:58\u201362","journal-title":"J Virol Methods"},{"issue":"15","key":"4171_CR30","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.vaccine.2006.12.031","volume":"25","author":"SE Sloan","year":"2007","unstructured":"Sloan SE, Hanlon C, Weldon W, Niezgoda M, Blanton J, Self J, Rowley KJ, Mandell RB, Babcock GJ, Thomas WD Jr, Rupprecht CE, Ambrosino DM (2007) Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates. Vaccine 25(15):2800\u20132810","journal-title":"Vaccine"},{"issue":"3","key":"4171_CR31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jmv.10408","volume":"70","author":"I Stephenson","year":"2003","unstructured":"Stephenson I, Wood JM, Nicholson KG, Zambon MC (2003) Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin. J Med Virol 70(3):391\u2013398","journal-title":"J Med Virol"},{"issue":"5","key":"4171_CR32","doi-asserted-by":"crossref","first-page":"e5476","DOI":"10.1371\/journal.pone.0005476","volume":"4","author":"L Sun","year":"2009","unstructured":"Sun L, Lu X, Li C, Wang M, Liu Q, Li Z, Hu X, Li J, Liu F, Li Q, Belser JA, Hancock K, Shu Y, Katz JM, Liang M, Li D (2009) Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses. PLoS One 4(5):e5476","journal-title":"PLoS One"},{"issue":"11","key":"4171_CR33","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.vaccine.2004.09.013","volume":"23","author":"K Suwansrinon","year":"2005","unstructured":"Suwansrinon K, Jaijaroensup W, Daviratanasilpa S, Sriaroon C, Wilde H, Sitprija V (2005) Adverse reactions to human rabies immune globulin manufactured by the Thai Red Cross Society. Vaccine 23(11):1324\u20131325","journal-title":"Vaccine"},{"issue":"2","key":"4171_CR34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.trstmh.2006.04.009","volume":"101","author":"K Suwansrinon","year":"2007","unstructured":"Suwansrinon K, Jaijareonsup W, Wilde H, Benjavongkulchai M, Sriaroon C, Sitprija V (2007) Sex- and age-related differences in rabies immunoglobulin hypersensitivity. Trans R Soc Trop Med Hyg 101(2):206\u2013208","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-012-4171-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-012-4171-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-012-4171-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T18:35:39Z","timestamp":1594319739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-012-4171-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,9]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["4171"],"URL":"https:\/\/doi.org\/10.1007\/s00253-012-4171-4","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,9]]}}}